Lexaria Bioscience Extends Warrant Term OCTOBER
Post# of 721
(Total Views: 239)
Posted On: 10/26/2020 2:35:42 PM
Lexaria Bioscience Extends Warrant Term
OCTOBER 26, 2020 2:30PM EDT
KELOWNA, BC / ACCESSWIRE / October 26, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"
, a global innovator in oral drug delivery platforms, has determined to extend the term of an aggregate 1,823,745 share purchase warrants (the "Warrants" , which were issued pursuant to a private placement of units.
The Warrants were issued in two tranches pursuant to which 1,554,245 Warrants were issued on November 13, 2019 and 269,500 Warrants were issued on November 28, 2019. The Warrants currently have a two year term whereby they are exercisable at a price of US$0.80 per share until the first anniversary of issuance and thereafter are exercisable at a price of US$1.20 until the end of the term.
The Warrant term will be extended, pursuant to Canadian Securities Exchange policy, from two years to five years with no changes to the exercise price. The Warrants will remain exercisable at a price of US$0.80 per share until the first year anniversary of issuance and thereafter at a price of US$1.20 until the end of the extended term, being November 13, 2024 as to 1,554,245 Warrants and November 28, 2024 as to 269,500 Warrants.
https://www.lexariabioscience.com
OCTOBER 26, 2020 2:30PM EDT
KELOWNA, BC / ACCESSWIRE / October 26, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"
, a global innovator in oral drug delivery platforms, has determined to extend the term of an aggregate 1,823,745 share purchase warrants (the "Warrants" , which were issued pursuant to a private placement of units. The Warrants were issued in two tranches pursuant to which 1,554,245 Warrants were issued on November 13, 2019 and 269,500 Warrants were issued on November 28, 2019. The Warrants currently have a two year term whereby they are exercisable at a price of US$0.80 per share until the first anniversary of issuance and thereafter are exercisable at a price of US$1.20 until the end of the term.
The Warrant term will be extended, pursuant to Canadian Securities Exchange policy, from two years to five years with no changes to the exercise price. The Warrants will remain exercisable at a price of US$0.80 per share until the first year anniversary of issuance and thereafter at a price of US$1.20 until the end of the extended term, being November 13, 2024 as to 1,554,245 Warrants and November 28, 2024 as to 269,500 Warrants.
https://www.lexariabioscience.com
(0)
(0)Lexaria Bioscience Corp. (LXRPD) Stock Research Links
Scroll down for more posts ▼